Faoud T. Ishmael
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Faoud T. Ishmael has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Ronaldo Paolo Panganiban
Division of Gastroenterology and Hepatology, Department of Medicine, The Pennsylvania State University, Hershey, PA 17033, USA
3 shared publications Simin Zhang
The Pennsylvania State University Milton S. Hershey Medical Center
3 shared publications- Kristin A. Lambert
Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania
2 shared publications - Man-Hsun Hsu
Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pa
2 shared publications Zoe Laryea
Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, The Pennsylvania State University Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA 17033, USA
2 shared publicationsAlanna Roff
Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, Pennsylvania State University College of Medicine Hershey, PA 17033, USA
1 shared publication
Latest Publications
- 17 May 2019
- Published by Springer Nature
- p. 491-504
Drug Allergy and Adverse Drug Reactions
- 1 January 2018
- Vol. 7 (4) , 57-+
Effects of allergic stimulation and glucocorticoids on miR-155 in CD4+ T-cells
Rationale: MicroRNAs (miRNAs) are emerging as important regulators of allergic inflammation and potential therapeutic targets. We sought to identify which miRNAs are expressed in CD4(+) T-cells and determine whether allergic stimuli or glucocorticoids alter their expression. Methods: After IRB approval, blood was collected from dust mite (DM) allergic rhinitis subjects (n=20), non-allergic controls (n=8), and asthmatics (n=16). Peripheral blood mononuclear cells were incubated with dust mite extract (DME), diluent control, or DME + dexamethasone (0.1 pM). CD4(+)T-cells were collected by magnetic bead column, and RNA was isolated by guanidinium/phenol-chloroform extraction. MicroRNA expression was measured using Nanostring microarray and quantitative real time PCR (qPCR). Results: We identified 196 miRNAs that were stably expressed in circulating CD4(+) T-cells. Allergen stimulation of CD4(+) T-cells with DME differentially induced miR-155 expression in cells of DM-allergic subjects as compared to non-allergic subjects. Induction of miR-155 expression was also observed with anti-CD3/anti-CD28 simulation and phorbol-12-Myristate-13-Acetate (PMA) treatment, and further augmented by calcium inophore and bromocyclic AMP in the latter treatment. The level of miR-155 expression was positively associated with expression of the T(H)2 cytokines IL-5 and IL-13. Inhibition of miR-155 in Jurkat T-cells inhibited the production of these cytokines. Glucocorticoids attenuated the effects of dust mite allergen, raising the possibility that inhibition of this miRNA could be a mechanism through which glucocorticoids exhibit their anti-inflammatory effects. The CD4(+) T-cells had a higher level of miR-155 expression in asthma compared to in allergic rhinitis and non-asthmatics. The inhibitory effects of glucocorticoids on CD4(+) T-cell miR-155 expression were lost in severe asthmatics. Conclusion: Mir-155 is differentially expressed in allergic T-cells exposed to DM extract compared to in non-allergic cells and it is inhibited by glucocorticoids. MiR-155 may play a role in mediating allergic inflammation in T-cells and could be an anti-inflammatory target of steroids. This pathway may be de-regulated in severe asthma.
- 1 January 2018
- Vol. 7 (4) , 57-+
Effects of allergic stimulation and glucocorticoids on miR-155 in CD4+ T-cells
Rationale: MicroRNAs (miRNAs) are emerging as important regulators of allergic inflammation and potential therapeutic targets. We sought to identify which miRNAs are expressed in CD4(+) T-cells and determine whether allergic stimuli or glucocorticoids alter their expression. Methods: After IRB approval, blood was collected from dust mite (DM) allergic rhinitis subjects (n=20), non-allergic controls (n=8), and asthmatics (n=16). Peripheral blood mononuclear cells were incubated with dust mite extract (DME), diluent control, or DME + dexamethasone (0.1 pM). CD4(+)T-cells were collected by magnetic bead column, and RNA was isolated by guanidinium/phenol-chloroform extraction. MicroRNA expression was measured using Nanostring microarray and quantitative real time PCR (qPCR). Results: We identified 196 miRNAs that were stably expressed in circulating CD4(+) T-cells. Allergen stimulation of CD4(+) T-cells with DME differentially induced miR-155 expression in cells of DM-allergic subjects as compared to non-allergic subjects. Induction of miR-155 expression was also observed with anti-CD3/anti-CD28 simulation and phorbol-12-Myristate-13-Acetate (PMA) treatment, and further augmented by calcium inophore and bromocyclic AMP in the latter treatment. The level of miR-155 expression was positively associated with expression of the T(H)2 cytokines IL-5 and IL-13. Inhibition of miR-155 in Jurkat T-cells inhibited the production of these cytokines. Glucocorticoids attenuated the effects of dust mite allergen, raising the possibility that inhibition of this miRNA could be a mechanism through which glucocorticoids exhibit their anti-inflammatory effects. The CD4(+) T-cells had a higher level of miR-155 expression in asthma compared to in allergic rhinitis and non-asthmatics. The inhibitory effects of glucocorticoids on CD4(+) T-cell miR-155 expression were lost in severe asthmatics. Conclusion: Mir-155 is differentially expressed in allergic T-cells exposed to DM extract compared to in non-allergic cells and it is inhibited by glucocorticoids. MiR-155 may play a role in mediating allergic inflammation in T-cells and could be an anti-inflammatory target of steroids. This pathway may be de-regulated in severe asthma.
- Open Access
- 1 January 2018
- Published by OAE Publishing Inc.
Plasma microRNA profiles identify distinct clinical phenotypes in human asthmatics
Journal of Translational Genetics and Genomics is an open access journal, publishing articles related to single gene disorders, rare genetic disease, specific genetic syndromes, complex disease, etc.
- 1 January 2018
- Published by OAE Publishing Inc.
Open AccessPlasma microRNA profiles identify distinct clinical phenotypes in human asthmatics
Journal of Translational Genetics and Genomics is an open access journal, publishing articles related to single gene disorders, rare genetic disease, specific genetic syndromes, complex disease, etc.